Troeberg Linda, Fushimi Kazunari, Khokha Rama, Emonard Hervé, Ghosh Peter, Nagase Hideaki
Kennedy Institute of Rheumatology Division, Imperial College London, 65 Aspenlea Rd, Hammersmith, London, W6 8LH, UK.
FASEB J. 2008 Oct;22(10):3515-24. doi: 10.1096/fj.08-112680. Epub 2008 Jul 16.
Degradation of the cartilage proteoglycan aggrecan is a key early event in the development of osteoarthritis. Adamalysin with thrombospondin motifs (ADAMTS) -4 and ADAMTS-5 are considered to be the main enzymes responsible for aggrecan breakdown, making them attractive drugs targets. Here we show that calcium pentosan polysulfate (CaPPS), a chemically sulfated xylanopyranose from beechwood, is a multifaceted exosite inhibitor of the aggrecanases and protects cartilage against aggrecan degradation. CaPPS interacts with the noncatalytic spacer domain of ADAMTS-4 and the cysteine-rich domain of ADAMTS-5, blocking activity against their natural substrate aggrecan with inhibitory concentration 50 values of 10-40 nM but only weakly inhibiting hydrolysis of a nonglycosylated recombinant protein substrate. In addition, CaPPS increased cartilage levels of tissue inhibitor of metalloproteinases-3 (TIMP-3), an endogenous inhibitor of ADAMTS-4 and -5. This was due to the ability of CaPPS to block endocytosis of TIMP-3 mediated by low-density lipoprotein receptor-related protein. CaPPS also increased the affinity of TIMP-3 for ADAMTS-4 and -5 by more than 100-fold, improving the efficacy of TIMP-3 as an aggrecanase inhibitor. Studies with TIMP-3-null mouse cartilage indicated that CaPPS inhibition of aggrecan degradation is TIMP-3 dependent. These unique properties make CaPPS a prototypic disease-modifying agent for osteoarthritis.
软骨蛋白聚糖聚集蛋白聚糖的降解是骨关节炎发展过程中的一个关键早期事件。含血小板反应蛋白基序的解聚素(ADAMTS)-4和ADAMTS-5被认为是负责聚集蛋白聚糖分解的主要酶,这使其成为有吸引力的药物靶点。在此我们表明,戊聚糖硫酸钙(CaPPS),一种来自山毛榉木的化学硫酸化吡喃木糖,是聚集蛋白聚糖酶的多方面外位点抑制剂,并能保护软骨免受聚集蛋白聚糖降解。CaPPS与ADAMTS-4的非催化间隔域和ADAMTS-5的富含半胱氨酸域相互作用,以10 - 40 nM的半数抑制浓度阻断对其天然底物聚集蛋白聚糖的活性,但仅微弱抑制非糖基化重组蛋白底物的水解。此外,CaPPS提高了金属蛋白酶组织抑制剂-3(TIMP-3)的软骨水平,TIMP-3是ADAMTS-4和-5的内源性抑制剂。这是由于CaPPS能够阻断由低密度脂蛋白受体相关蛋白介导的TIMP-3的内吞作用。CaPPS还使TIMP-3对ADAMTS-4和-5的亲和力提高了100多倍,提高了TIMP-3作为聚集蛋白聚糖酶抑制剂的功效。对TIMP-3基因敲除小鼠软骨的研究表明,CaPPS对聚集蛋白聚糖降解的抑制作用是TIMP-3依赖性的。这些独特特性使CaPPS成为骨关节炎的一种原型疾病改善剂。